Humpback whale enjoys an expanse
Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Noronex Limited (ASX:NRX) has kicked off a gravity EM survey at the Humpback-Damara project in Namibia – part of its earn-in deal with South32.

Perhaps surprising to regular explorer-watchers is the news that South32 wants copper acreage, and it’s come knocking on Noronex’s door – as opposed to a small company hoping to farm-into a bigger operation.

Notably, Noronex is funded by South32 to do this work on its 100% owned tenements to the tune of A$0.75M.

A total of four areas will be covered, sniffing around an area believed to be an extension of the famous Kalahari Copper Belt (KCB) in Africa. That survey will – all cards in order – define future drill targets.

That drilling is set to take place “later in the quarter” – an indication South32 doesn’t want to waste any time. It’s seeking to earn up to 60% according to an initial announcement from Noronex in June.

Noronex has reported historical and recent drilling yields results not unlike those pulled from the KCB 400km eastward in Botswana. It pointed to another company’s project in that region which boasts an average frade of 2.1% copper.

If it isn’t obvious, 400km is quite extreme to claim nearology, but then again, the KCB is well known because it’s geologically massive. Assays will be needed to further indicate mineralisation styles at Humpback-Damara.

NRX last traded at 1.4cps.

nrx by the numbers
More From The Market Online

Listen: HotCopper Wire Podcast #047 – Maybe just send an email next time, Albo

In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson break down (poke holes in) Albo’s national address from 7PM Wednesday, talk
The Market Online Video

Introducing Prairie Lithium: Saskatchewan’s permitted lithium project ready to scale

We've spoken to Prairie Lithium founder Zach Maurer about the explorer's overall mission, right after Macquarie's…
The Market Online Video

US growth, injectable iron pipeline: How AFT Pharma is driving toward $300 million by FY27

AFT Pharmaceuticals (ASX:AFP) is in a red-hot position as we head straight into FY26’s fourth quarter in Australia, and
The Market Online graphic with ASX-branded charts and the text "HotCopper Highlights" centred in white.

HotCopper Highlights, Week 15: Santos, Karoon, Viva all riding the Iran-fuelled Energy rollercoaster

Hello, hello, and welcome to HotCopper Highlights for Week 15, CY26, I’m Isaac McIntyre.